These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 205091)

  • 1. Receptors acting through adenylate cyclase in the CNS.
    Wollemann M
    Acta Physiol Acad Sci Hung; 1980; 55(4):299-304. PubMed ID: 6258390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M-1 and M-2 muscarinic receptor-mediated inhibition of dopamine-sensitive adenylate cyclase in rat neostriatum: a permissive role for D-2 dopamine receptors.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    J Pharmacol Exp Ther; 1988 May; 245(2):658-63. PubMed ID: 2452877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine modulation of synaptic responses in rat hippocampus: possible role of inhibition or activation of adenylate cyclase.
    Dunwiddie TV; Fredholm BB
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985; 19():259-72. PubMed ID: 2988300
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
    Roseboom PH; Gnegy ME
    Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
    Cooper DM; Bier-Laning CM; Halford MK; Ahlijanian MK; Zahniser NR
    Mol Pharmacol; 1986 Feb; 29(2):113-9. PubMed ID: 3005824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties and localization of dopamine-sensitive adenylate cyclase in the carp retina.
    Van Buskirk R; Watling KJ
    Fed Proc; 1984 Sep; 43(12):2719-24. PubMed ID: 6205901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the possible role of adenosine as a modulatory messenger in the hippocampus and other regions of the CNS.
    Schubert P; Reddington M; Kreutzberg GW
    Prog Brain Res; 1979; 51():149-65. PubMed ID: 233162
    [No Abstract]   [Full Text] [Related]  

  • 8. D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture.
    Weiss S; Sebben M; Garcia-Sainz JA; Bockaert J
    Mol Pharmacol; 1985 Jun; 27(6):595-9. PubMed ID: 2987658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optic tectum adenylate cyclase activity from goldfish (Carassius auratus) as a model to assess dopamine receptor agonists and antagonists.
    De Sarro A; De Gori N; Urna G; Pujia A; Nistico' G
    Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):241-9. PubMed ID: 6133329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of dopamine sensitive adenylate cyclase in hippocampus reinnervated by transplanted dopamine neurons: evidence for new functional contacts.
    Stenevi U; Emson P; Björklund A
    Acta Physiol Scand Suppl; 1977; 452():39-42. PubMed ID: 205091
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.
    Enjalbert A; Bockaert J
    Mol Pharmacol; 1983 May; 23(3):576-84. PubMed ID: 6306429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus.
    Dunwiddie TV; Fredholm BB
    J Pharmacol Exp Ther; 1989 Apr; 249(1):31-7. PubMed ID: 2565393
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.